D-Risk Investing Podcast

Is Datavault AI's $150 million Bitcoin-funded supercomputer strategy a game-changer, or is its money-losing past too heavy a burden? This episode of D-Risk dives into the high-stakes battle over ticker DVLT, where the market is cheering a spectacular, forward-looking catalyst while the company's intrinsic worth still whispers a mere $0.33 per share. With short-sellers betting against the stock's explosive breakout and technical indicators flashing "overbought," we analyze whether a powerful short squeeze is about to ignite or if fundamental gravity will pull the price back to earth. Join us for a no-nonsense analysis of DVLT's technical trends, valuation disconnect, and market sentiment.

AI darling Astera Labs (ALAB) was one of the market's highest flyers, but what happens when giants like Intel and Nvidia threaten to step on its turf? A sudden 10% plunge has turned this stock into a major battleground, pitting bullish Wall Street analysts against a starkly bearish reality: its cash-flow valuation is a mere $17, yet it trades for over $200. With the technical charts confirming a violent, high-volume breakdown and short-sellers smelling blood, the central question is urgent. In this episode, we dissect the data to determine if this is a golden buying opportunity or the beginning of a catastrophic collapse for a massively overvalued company.

What happens when a biotech company announces a potential miracle cure and, mere hours later, hands the market a $100 million bill? That's the complex diagnosis facing PepGen (PEPG) after a bombshell clinical trial announcement sent its stock exploding upwards on stampede-like volume, only to be followed by a massive, dilutive share offering. With a significant number of traders betting against it and a chart screaming both "breakout" and "dangerously overbought," the stock is now a major battleground. In this episode, we dissect the conflict between groundbreaking science and financial reality to determine if this explosive rally has a healthy prognosis or if it's just a flash of market fever destined to fade.